Caleres (CAL) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Fiscal 2024 saw both challenges and opportunities, with investments in brands and capabilities, disciplined expense management, and significant cash returned to shareholders through dividends and repurchases.
Brand Portfolio achieved strong adjusted operating earnings and margin, while Famous Footwear increased market share in key segments.
Consolidated net sales decreased 3.4% to $2.72B, and adjusted net earnings were $114.6M, with $74.7M returned to shareholders.
Structural changes have made the organization more agile and efficient, positioning it for future growth.
Voting matters and shareholder proposals
Shareholders will vote on the election of eleven director nominees, ratification of Ernst & Young LLP as independent auditors, approval of executive compensation (Say on Pay), and any other properly raised matters.
The board recommends a vote FOR all proposals.
Board of directors and corporate governance
Eleven director nominees are up for election for one-year terms; the board is declassified and all directors are elected annually.
10 of 12 directors are independent; half are female and 18% are racially/ethnically diverse.
Committees include Audit, Culture/Compensation/People, Executive, Governance/Nominating, and Technology/Digital Commerce, all chaired by independent directors.
The board conducts annual self-evaluations and maintains a director resignation policy for non-majority votes.
Upon the annual meeting, the roles of chair and CEO will remain separate, with Ward M. Klein to become chair.
Latest events from Caleres
- Sales down 1.8% as ERP disruptions and weak demand led to lower results and revised guidance.CAL
Q2 202520 Jan 2026 - Q3 sales fell 2.8% to $740.9M, with lower earnings but market share gains and strong buybacks.CAL
Q3 202511 Jan 2026 - FY24 met guidance; FY25 outlook cautious with Stuart Weitzman acquisition and sourcing shift.CAL
Q4 202526 Dec 2025 - Sales up 6.6% with strong brands, but margins and EPS pressured by tariffs and integration.CAL
Q3 202611 Dec 2025 - Shareholders to vote on directors, executive pay, and auditor ratification at annual meeting.CAL
Proxy Filing1 Dec 2025 - Sales and earnings fell, but market share gains and cost-saving actions provide optimism.CAL
Q1 202626 Nov 2025 - Lead brands, DTC growth, and cost savings drive performance amid tariff challenges.CAL
2025 Global Consumer & Retail Conference8 Oct 2025 - Q2 sales fell 3.6% as margin pressures persisted, but cost savings and liquidity improved.CAL
Q2 20269 Sep 2025